Bethany J. Cavanagh's most recent trade in Beam Therapeutics Inc was a trade of 3,242 Common Stock done at an average price of $24.6 . Disclosure was reported to the exchange on April 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | Sale of securities on an exchange or to another person at price $ 24.58 per share. | 01 Apr 2026 | 3,242 | 51,171 (0%) | 0% | 24.6 | 79,688 | Common Stock |
| Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 20,000 | 54,813 (0%) | 0% | 0 | Common Stock | |
| Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2026 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 22 Jan 2026 | 6,198 | 34,813 (0%) | 0% | 35.0 | 216,933 | Common Stock |
| Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | Sale of securities on an exchange or to another person at price $ 30.12 per share. | 20 Jan 2026 | 3,034 | 41,011 (0%) | 0% | 30.1 | 91,384 | Common Stock |
| Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | Sale of securities on an exchange or to another person at price $ 24.53 per share. | 01 Oct 2025 | 467 | 44,045 (0%) | 0% | 24.5 | 11,456 | Common Stock |
| Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | Sale of securities on an exchange or to another person at price $ 18.35 per share. | 01 Apr 2025 | 3,015 | 44,512 (0%) | 0% | 18.4 | 55,330 | Common Stock |
| Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 10,000 | 47,527 (0%) | 0% | 0 | Common Stock | |
| Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 18 Feb 2025 | 6,287 | 37,527 (0%) | 0% | 35 | 220,045 | Common Stock |
| Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | Sale of securities on an exchange or to another person at price $ 24.68 per share. | 02 Jan 2025 | 1,117 | 43,814 (0%) | 0% | 24.7 | 27,568 | Common Stock |
| Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | 30 Sep 2024 | 2,500 | 45,220 (0%) | 0% | 0 | Common Stock | ||
| Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | 30 Sep 2024 | 289 | 44,931 (0%) | 0% | 23.5 | 6,785 | Common Stock | |
| Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | 31 Aug 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) |